Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | 98,493 | reported | 04 Mar 2026 | tx 292+1,278,850−806,278 |
| Molecular Insight Pharmaceuticals, Inc. | 25,000 | reported | 22 Sept 2008 | tx 1+25,000 |
| Pacira BioSciences, Inc. | 8,225 | reported | 08 Jun 2022 | tx 18+82,944 |
| Moelis & Co | 1,156.96 | reported | 14 Nov 2018 | tx 50+8,539.49 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 973 | 323.84 USD | |
| 04 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 444 | 323.01 USD | |
| 04 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 368 | 321.82 USD | |
| 04 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 274 | 320.81 USD | |
| 04 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 265 | 325.67 USD | |
| 04 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 135 | 319.03 USD | |
| 04 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 345 | 324.88 USD | |
| 04 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 129 | 320.01 USD | |
| 02 Mar 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 13,844 | 0.00 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 200 | 323.62 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 382 | 324.65 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 399 | 331.93 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1,669 | 326.81 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1,399 | 327.67 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 424 | 328.71 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 722 | 329.71 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 346 | 330.85 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 160 | 332.64 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1,098 | 325.63 USD | |
| 02 Mar 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 110,746 | 0.00 USD | deriv |
| 02 Mar 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 30,425 | 0.00 USD | deriv |
| 27 Feb 2026 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 5,921 | 0.00 USD | |
| 27 Feb 2026 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 5,921 | 0.00 USD | deriv |
| 13 Feb 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 6,958 | 310.08 USD | |
| 12 Feb 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 14,209 | 0.00 USD |